Inventor · disambiguated record
Henry Luke Danahay
Also filed as: DANAHAY HENRY L · DANAHAY HENRY LUKE
13 granted patents·8 pending applications·121 citations·filing 2001–2022
93Inventor score
Files withARROWHEAD PHARMACEUTICALS INC5NOVARTIS AG5VAN HEEKE GINO3ARROWHEAD RES CORP1CLARKE JEREMY G1
Top patents by PatentIndex Score
21 records- 0196US7718632B2RNAi inhibition of alpha-ENaC expressionNOVARTIS AG·Filed 2008·Granted May 18, 2010·24 cites·27 claims
- 0295US7943592B2RNAi inhibition of alpha-ENaC expressionNOVARTIS AG·Filed 2010·Granted May 17, 2011·18 cites·20 claims
- 0395US7939508B2RNAi inhibition of alpha-ENaC expressionNOVARTIS AG·Filed 2010·Granted May 10, 2011·18 cites·23 claims
- 0493US8168606B2RNAi inhibition of alpha-ENaC expressionVAN HEEKE GINO·Filed 2010·Granted May 1, 2012·15 cites·23 claims
- 0587US9074212B2RNAi inhibition of alpha-ENaC expressionVAN HEEKE GINO·Filed 2010·Granted Jul 7, 2015·6 cites·20 claims
- 0687US8119612B2RNAi inhibition of alpha-ENaC expressionVAN HEEKE GINO·Filed 2010·Granted Feb 21, 2012·6 cites·23 claims
- 0787US7566705B2Combination of formoterol and mometasone furoate for asthmaNOVARTIS AG·Filed 2005·Granted Jul 28, 2009·12 cites·20 claims
- 0884US9476052B2RNAi inhibition of alpha-ENaC expressionARROWHEAD RES CORP·Filed 2015·Granted Oct 25, 2016·2 cites·20 claims
- 0983US7067502B2Combinations of formoterol and mometasone furoate for asthmaNOVARTIS AG·Filed 2003·Granted Jun 27, 2006·16 cites·21 claims
- 1082US2022235361A1RNAi Inhibition of Alpha-ENaC ExpressionARROWHEAD PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1181US10544418B2RNAi inhibition of alpha-ENaC expressionARROWHEAD PHARMACEUTICALS INC·Filed 2018·Granted Jan 28, 2020·1 cites·13 claims
- 1281US2022112505A1RNAi Inhibition of Alpha-ENaC ExpressionARROWHEAD PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1376US11208662B2RNAi inhibition of alpha-ENaC expressionARROWHEAD PHARMACEUTICALS INC·Filed 2020·Granted Dec 28, 2021·0 cites·21 claims
- 1470US9944700B2Notch2 binding molecules for treating respiratory diseasesDANAHAY HENRY LUKE·Filed 2014·Granted Apr 17, 2018·3 cites·7 claims
- 1567US9914927B2RNAi inhibition of alpha-ENaC expressionARROWHEAD PHARMACEUTICALS INC·Filed 2016·Granted Mar 13, 2018·0 cites·20 claims
- 1664US2010034890A1Combinations of formoterol and fluticasone propionate for asthmaCLARKE JEREMY GUY·Filed 2009·Application pending·0 cites
- 1753US2005287079A1Combinations of formoterol and fluticasone propionate for asthmaCLARKE JEREMY G·Filed 2005·Application pending·0 cites
- 1852US2004101487A1Combinations of formoterol and fluticasone propionate for asthmaFiled 2003·Application pending·0 cites
- 1950US2003050290A1Combination of formoterol and mometasone furoate for asthmaFiled 2002·Application pending·0 cites
- 2048US2002055494A1Combinations of formoterol and mometasone furoate for asthmaFiled 2001·Application pending·0 cites
- 2147US2002103260A1Combinations of formoterol and fluticasone proppionate for asthmaFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Henry Luke Danahay files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →